These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7484889)

  • 1. Disparate effects of antihypertensive drugs on large artery distensibility and compliance in hypertension.
    Van Bortel LM; Kool MJ; Spek JJ
    Am J Cardiol; 1995 Nov; 76(15):46E-49E. PubMed ID: 7484889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vessel wall properties of large arteries in hypertension and effect of antihypertensive treatment.
    Van Bortel LM; Kool MJ
    Can J Cardiol; 1994 Nov; 10 Suppl D():37D-40D. PubMed ID: 7954040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of perindopril and the diuretic combination amiloride+hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients.
    Kool MJ; Lustermans FA; Breed JG; Struyker Boudier HA; Hoeks AP; Reneman RS; Van Bortel LM
    J Hypertens; 1995 Aug; 13(8):839-48. PubMed ID: 8557961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antihypertensive agents on local arterial distensibility and compliance.
    Van Bortel LM; Kool MJ; Boudier HA; Struijker Boudier HA
    Hypertension; 1995 Sep; 26(3):531-4. PubMed ID: 7649594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular effects of perindopril: from experimental to clinical investigation.
    Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to large artery properties as a target for risk reduction by antihypertensive therapy.
    Van Bortel LM; Hoeks AP; Kool MJ; Struijker-Boudier HA
    J Hypertens Suppl; 1992 Aug; 10(6):S123-6. PubMed ID: 1432313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of ACE inhibition by perindopril.
    Michel JB; Levy BI
    Drugs; 1990; 39 Suppl 1():39-42. PubMed ID: 2407491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose optimization study of arterial changes associated with angiotensin converting enzyme inhibition in hypertension.
    Asmar RG; Iannascoli F; Benetos A; Safar ME
    J Hypertens Suppl; 1992 Jul; 10(5):S13-9. PubMed ID: 1403229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effect of antihypertensive drugs on conduit artery endothelial function.
    Ghiadoni L; Magagna A; Versari D; Kardasz I; Huang Y; Taddei S; Salvetti A
    Hypertension; 2003 Jun; 41(6):1281-6. PubMed ID: 12719441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of perindopril and amiloride/hydrochlorothiazide on haemodynamics and vessel wall properties of large arteries.
    Kool MJ; Lustermans FA; Breed JG; Struyker-Boudier HA; Hoeks AP; Van Bortel LM
    J Hypertens Suppl; 1993 Dec; 11(5):S362-3. PubMed ID: 8158423
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover study.
    Topouchian J; Brisac AM; Pannier B; Vicaut E; Safar M; Asmar R
    J Hum Hypertens; 1998 Mar; 12(3):181-7. PubMed ID: 9579768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study PROTECT (Perindopril Regression of Vascular Thickening). European Community Trial].
    Tarentini Trojani F
    Clin Ter; 1994 Nov; 145(11):411-2. PubMed ID: 7889727
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
    Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
    Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic converting enzyme inhibition on the structure and function of large arteries in the rat.
    Levy BI; Michel JB; Salzmann JL; Devissaguet M; Camilleri JP; Safar ME
    Clin Exp Hypertens A; 1989; 11 Suppl 2():487-98. PubMed ID: 2605798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition, pulse wave velocity and ambulatory blood pressure measurements in essential hypertension.
    Santoni JP; Asmar R; Safar ME
    Clin Exp Hypertens A; 1989; 11 Suppl 2():535-44. PubMed ID: 2691127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac hypertrophy and arterial compliance after antihypertensive treatment].
    Asmar RG; Pannier BM; London GM; Safar ME
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():79-83. PubMed ID: 1838923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
    Schiffrin EL
    Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension.
    Hayoz D; Tardy Y; Perret F; Waeber B; Meister JJ; Brunner HR
    J Hypertens Suppl; 1992 Jul; 10(5):S95-100. PubMed ID: 1328567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension.
    Lafleche A; Gautier S; Topouchian J; Wilmet CS; Girerd X; Safar ME; Benetos A
    Clin Pharmacol Ther; 1998 Jul; 64(1):96-105. PubMed ID: 9695724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The blood vessel as a target organ in hypertension: protective effect of perindopril.
    Plante GE
    Can J Cardiol; 1994 Nov; 10 Suppl D():25D-29D. PubMed ID: 7954036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.